Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Court cases targeting big pharma are just a taste of what is to come
US president Donald Trump backs down on asking about citizenship in 2020 US census
Reckitt Benckiser’s $1.4bn settlement is the largest penalty so far linked to the epidemic
Deal over addiction treatment marketing is largest fine so far in painkiller epidemic
$1.4bn settlement is huge but has put end to troublesome source of cost, doubt and distraction
OneFifteen in Dayton aims to collect insights on 1,000 annual outpatient addicts
Lawyers for 1,800 plaintiffs vow to ‘actively pursue’ drugmakers regardless of Chapter 11 filing
Group buckles under weight of legal liabilities in wake of US addiction crisis
Group admits to illegal conduct when widely promoting fentanyl-based spray
Start-ups are testing the use of AI and smart medication boxes
Apps nudge addicts towards recovery and steer them away from risky contacts
Pharmaceuticals company settles ahead of trial over state’s drugs crisis
OxyContin maker has been accused of playing a key role in fuelling the US opioid crisis
US expected to redouble efforts to pursue criminal prosecutions while others chase civil claims
John Kapoor and 4 others found guilty of scheme to boost sales of highly addictive painkiller
Schultz likens claims against drugmakers to blaming drunk driving on makers of alcoholic drinks
Germany’s telecoms regulator says Huawei can stay in the 5G network race
Opioid maker sought drug group that treats abuse of its own painkillers
Consumer goods giant sheds £3bn in market value over potential exposure to opioid charges
UK-listed drugmaker vows to contest allegations as shares fall more than 70%
Purdue Pharma owners file motion to dismiss lawsuit from Massachusetts attorney-general
Efforts to staunch flow of synthetic opioids seen as sign of progress in trade talks
State files ‘nation’s most extensive lawsuit’ against a raft of drugmakers and distributors
Deal with Oklahoma by Purdue Pharma and Sackler family owners could be first of many
US opioid crisis campaigner plans to target unnamed arts organisation in London
